Preoperative left atrial minimum volume as a surrogate marker of postoperative symptoms in senile patients with aortic stenosis who underwent surgical aortic valve replacement.


Journal

Journal of cardiology
ISSN: 1876-4738
Titre abrégé: J Cardiol
Pays: Netherlands
ID NLM: 8804703

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 28 01 2019
revised: 14 03 2019
accepted: 02 04 2019
pubmed: 11 5 2019
medline: 9 7 2020
entrez: 11 5 2019
Statut: ppublish

Résumé

Previous reports have shown that postoperative symptoms despite successful surgical aortic valve replacement (AVR) are not uncommon depending on severity of myocardial fibrosis in patients with aortic stenosis (AS). Left atrial minimum volume (LAV We studied 75 patients with AS who underwent AVR and were followed up to 600 days after AVR. We examined the postoperative symptomatic status which occurred between 60 days to 600 days after AVR. The study patients were divided into 2 groups: 19 patients (25%) with postoperative symptoms (symptomatic group) and 56 without symptoms (asymptomatic group). There were no significant differences in preoperative left ventricular volumes and ejection fraction and AS severity by echocardiography between the two groups. There were significant differences in preoperative echocardiographic LAV The preoperative echocardiographic LAVI

Sections du résumé

BACKGROUND BACKGROUND
Previous reports have shown that postoperative symptoms despite successful surgical aortic valve replacement (AVR) are not uncommon depending on severity of myocardial fibrosis in patients with aortic stenosis (AS). Left atrial minimum volume (LAV
METHODS AND RESULTS RESULTS
We studied 75 patients with AS who underwent AVR and were followed up to 600 days after AVR. We examined the postoperative symptomatic status which occurred between 60 days to 600 days after AVR. The study patients were divided into 2 groups: 19 patients (25%) with postoperative symptoms (symptomatic group) and 56 without symptoms (asymptomatic group). There were no significant differences in preoperative left ventricular volumes and ejection fraction and AS severity by echocardiography between the two groups. There were significant differences in preoperative echocardiographic LAV
CONCLUSIONS CONCLUSIONS
The preoperative echocardiographic LAVI

Identifiants

pubmed: 31072724
pii: S0914-5087(19)30100-5
doi: 10.1016/j.jjcc.2019.04.003
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

366-371

Informations de copyright

Copyright © 2019 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Auteurs

Junko Morimoto (J)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan; Department of Cardiovascular Medicine, Arida City Hospital, Arida, Japan.

Takeshi Hozumi (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan. Electronic address: takeshi.hozumi@gmail.com.

Kazushi Takemoto (K)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Teruaki Wada (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Naoki Maniwa (N)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Manabu Kashiwagi (M)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Kunihiro Shimamura (K)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yasutsugu Shiono (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Akio Kuroi (A)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Takashi Yamano (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Tomoyuki Yamaguchi (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yoshiki Matsuo (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Hironori Kitabata (H)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yasushi Ino (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Takashi Kubo (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Atsushi Tanaka (A)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yoshiharu Nishimura (Y)

Department of Cardiovascular Surgery, Wakayama Medical University, Wakayama, Japan.

Takashi Akasaka (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH